Robert J. Hugin - Dec 20, 2021 Form 4 Insider Report for Biohaven Pharmaceutical Holding Co Ltd. (BHVN)

Role: Director
Signature: /s/ George Clark, Attorney-in-Fact
Stock symbol: BHVN
Transactions as of: Dec 20, 2021
Transactions value $: $0
Form type: 4
Date filed: 12/22/2021, 08:52 PM
Previous filing: May 24, 2021
Next filing: Apr 29, 2022
SEC: View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	BHVN	Restricted Share Unit Award	Award	$0	+3.42K		$0.00	3.42K	Dec 20, 2021	Common Shares	3.42K		Direct	F1, F2, F3

Showing 1 to 1 of 1 entries

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Each restricted share unit represents the contingent right to receive one common share of the issuer.
F2	The reporting person was granted 3,417 restricted share units on December 20, 2021, which vested immediately upon grant. These restricted share units will settle on a deferred basis upon the reporting person's retirement from the Board of Directors of the issuer.
F3	Not applicable.

Remarks:

Exhibit List: Exhibit 24: Power of attorney